BLOOD-REPARP

5 Oct 2022 | Unclassified

BLOOD-REPARP: Circulating biomarkers of resistance to PARP inhibitors in HER2-negative metastatic breast cancer. PARP inhibitors improve progression free survival compared to standard chemotherapy ofHER2-negativemetastaticbreast cancer (mBC) patients bearing germline...

CIRComa

30 Sep 2022 | Unclassified

CIRComa : Deciphering the role of circular RNAs in the pathogenesis and therapeutic resistance of anaplastic large cell lymphomas associated with the oncogenic tyrosine kinase ALK. Deciphering the role of circular RNAs in the pathogenesis and therapeutic resistance of...

IMAGene

28 Sep 2022 | Unclassified

IMAGene : Pancreatic Cancer Prediction in high risk individuals. Epigenomic and machine learning models to predict pancreatic cancer: development of a new algorithm to integrate clinical, omics, DNA methylation biomarkers and environmental data for early detection of...

Web database about RNA structures called RNA G-Quarduplexes and their interaction with RNA binding proteins

23 Sep 2022 | Discover home page, Discover RNAreg, Unclassified

Web database about RNA structures called RNA G-Quarduplexes and their interaction with RNA binding proteins RNA G-Quadruplex RNA binding proteins database Sébastien Bourdon, RNAreg Teams – RNA-Binding Proteins and Genotoxic Stress RNA G-quadruplexes (RG4s) are...

TRanSLIT

19 Sep 2022 | Unclassified

TRanSLIT – Targeting ROBO-SLIT guidance signals in the context of immunosuppressive pancreatic cancer stroma. Pancreatic ductal adenocarcinoma (PDAC) is a cancer of high unmet need with rising incidence and bleak overall 5-year survival rates below 10%. The...

PET imaging of PD-L1 in a mouse model of lung cancer: zirconium-89 radiolabeling, pharmacokinetic modeling and dosimetry

21 Feb 2022 | CRCT Thesis, Unclassified

Anis Krache